
First adrenaline nasal spray for the treatment of anaphylaxis
The Medicines and Healthcare products Regulatory Agency (MHRA) announced on 18 July 2025, its approval of adrenaline (epinephrine) nasal spray (EURneffy) to be used for the emergency treatment of serious








